Source: Annual Congress 2011 - Lung development and neoplasia
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Struniawski, P. Kuca, A. Szpechcinski, M. Skronski, M. Czajkowska-Malinowska, J. Kozielski, P. Sliwinski, K. Górska, P. Korczynski, R. Krenke, R. Chazan, U. Oldakowska-Jedynak, M. Krawczyk, E. Jassem, H. Batura-Gabryel, J. Chorostowska-Wynimko (Warsaw, Bydgoszcz, Zabrze, Gdansk, Poznan, Poland). Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients. Eur Respir J 2011; 38: Suppl. 55, 3808

Member's Comments

No comment yet.

Related content which might interest you: Screening of chronic liver disease by transient elastography in patients with lung disease associated with alpha-1 antitrypsin deficiency. Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Lung function in relation to emphysema development in alpha-1 antitrypsin deficiency Source: International Congress 2019 – Insights into physiological diagnostic services Year: 2019 Exercise intolerance and lung emphysema in alpha-1 antitrypsin deficiency (AATD) Source: Annual Congress 2010 - Exercise in COPD Year: 2010 COPD and alpha-1 antitrypsin deficiency emphysema: characteristics and survival after Lung Transplantation Source: International Congress 2018 – Moving lung transplantation forward Year: 2018 Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease. Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019 The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes Source: Eur Respir J, 56 (6) 2001441; 10.1183/13993003.01441-2020 Year: 2020 Alpha-1 antitrypsin deficiency – a potentially fatal disease Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases Year: 2017 Alpha-1 antitrypsin deficiency and lung cancer: Description of a cohort of patients in northwestern Spain Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021 Functional alterations of small airways in patients with alpha-1 antitrypsin deficiency (AATD) in a longitudinal study Source: Eur Respir J 2005; 26: Suppl. 49, 361s Year: 2005 Substitution therapy in Alpha-1 antitrypsin deficiency after lung transplantation Source: Eur Respir J 2006; 28: Suppl. 50, 724s Year: 2006 Regional deposition of 99mTc-labelled alpha-1 antitrypsin (AAT) in patients with alpha-1 antitrypsin deficiency and cystic fibrosis (CF) compared with healthy volunteers Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects Year: 2007 Mechanisms of liver disease in AATD Source: Eur Respir Monogr 2019; 85: 93-104 Year: 2019 Alpha-1 antitrypsin deficiency in patients with COPD/emphysema, bronchiectasis and asthma Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 Monitoring disease progression in severe Alpha1 antitrypsin deficiency Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD Year: 2020 Alpha-1 antitrypsin deficiency severity and the risk of COVID-19 Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19 Year: 2021 GSTP1 polymorphisms in patients with COPD and alpha-1 antitrypsin deficiency Source: Eur Respir J 2003; 22: Suppl. 45, 384s Year: 2003 Trends in diagnosis and clinical presentation of alpha-1 antitrypsin deficiency within an Irish population Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Clinical features of alpha one antitrypsin deficiency in COPD Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012